Compare VCYT & EMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VCYT | EMAT |
|---|---|---|
| Founded | 2006 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.6B |
| IPO Year | 2013 | 2021 |
| Metric | VCYT | EMAT |
|---|---|---|
| Price | $25.09 | $0.61 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 2 |
| Target Price | ★ $41.60 | $7.37 |
| AVG Volume (30 Days) | ★ 2.6M | 892.3K |
| Earning Date | 11-04-2026 | 11-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 164.52 | N/A |
| EPS | ★ 1.04 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $14.24 | N/A |
| Revenue Next Year | $6.42 | $3,807.38 |
| P/E Ratio | $24.10 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $21.91 | $0.60 |
| 52 Week High | $60.91 | $17.50 |
| Indicator | VCYT | EMAT |
|---|---|---|
| Relative Strength Index (RSI) | 30.93 | 28.06 |
| Support Level | $21.91 | N/A |
| Resistance Level | $34.72 | $2.33 |
| Average True Range (ATR) | 2.13 | 0.25 |
| MACD | -0.72 | -0.06 |
| Stochastic Oscillator | 9.35 | 3.15 |
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder).
Evolution Metals & Technologies Corp is a critical materials and technology company. The company is focused on developing a secure, dependable, and self-sustaining U.S.-aligned supply chain for critical minerals and materials (CMM), and rare earth elements (REEs). The company is also engaged in recycling end-of-life materials through urban mining to help strengthen domestic resource independence and long-term supply stability.